Chase Therapeutics
Washington, US · Founded 2017
Biotech
Founders & leadership
TN
Thomas N. ChasePresident and Chief Executive Officer
RP
Richard P. DulikSecretary
KN
Kathleen N. Clarence-SmithDirector
Reported raises · per SEC filings
Form D private placements$4MraisedAug 2018 · 3 investors · Pharmaceuticals
Rule 506(b)$1.3MraisedNov 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.